ProteinQure
Dare to Deliver
- Headquarters
- Toronto
- Business Model
- B2B
- Website
- proteinqure.com
- Last Round
- Series AMay 2025
- Rounds
- 2
About
ProteinQure is a clinical-stage biotech company based in Toronto's life sciences hub, designing novel exotic peptides using atomic-level biophysics simulations and AI. The company's multidisciplinary team combines machine learning, computational biology, and experimental science to develop peptide therapeutics such as PQ203, the first AI-designed peptide to enter Phase I clinical trials, and has raised Series A financing to advance its pipeline.
Summary
ProteinQure is an Artificial Intelligence company based in Toronto, Canada. Its most recent funding was a Series A round in May 2025. Investors include Heron Rock Fund, Felicis Ventures and 8VC.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2025
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

Lila Sciences combines artificial intelligence with autonomous laboratories to accelerate scienti...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/proteinqure"><img src="https://indexed.vc/api/badge/company/proteinqure" alt="ProteinQure on Indexed.vc" width="260" height="76" /></a>

